AstraZeneca (AZN) RNS Announcements

Add to Alert list
Date Time Source Announcement
22 May 2014 11:00 AM
RNS
Rule 2.10 Announcement
22 May 2014 10:56 AM
BZW
Form 8.3 - Astrazeneca Plc
21 May 2014 02:59 PM
BZW
Form 8.3 - Astrazenica Plc
21 May 2014 02:48 PM
BZW
Form 8.3 - AstraZeneca Plc
21 May 2014 12:38 PM
BZW
Form 8.3 - AstraZeneca PLC
21 May 2014 12:34 PM
BZW
Form 8.3 - Astrazeneca Plc
21 May 2014 11:29 AM
RNS
Rule 2.10 Announcement
20 May 2014 06:17 PM
RNS
CLARIFICATION REGARDING PFIZER STATEMENT
20 May 2014 04:32 PM
BZW
Form 8.3 - Astrazenica Plc
20 May 2014 02:27 PM
BZW
Form 8.3 - AstraZeneca Plc
20 May 2014 01:51 PM
BZW
Form 8.3 - AstraZeneca PLC
20 May 2014 11:53 AM
BZW
Form 8.3 - Astrazeneca Plc
20 May 2014 11:00 AM
RNS
Rule 2.10 Announcement
19 May 2014 03:31 PM
BZW
Form 8.3 - AstraZeneca Plc
19 May 2014 03:26 PM
BZW
Form 8.3 - Astrazenica Plc
19 May 2014 01:13 PM
BZW
Form 8.3 - AstraZeneca PLC
19 May 2014 11:18 AM
BZW
Form 8.3 - Astrazeneca Plc
19 May 2014 11:00 AM
RNS
Rule 2.10 Announcement
19 May 2014 07:08 AM
RNS
ASTRAZENECA BOARD REJECTS PFIZER'S FINAL PROPOSAL
16 May 2014 03:14 PM
BZW
Form 8.3 - AstraZeneca Plc
16 May 2014 02:40 PM
BZW
Form 8.3 - AstraZeneca Plc
16 May 2014 01:54 PM
BZW
Form 8.3 - AstraZeneca PLC
16 May 2014 12:59 PM
BZW
Form 8.3 - Astrazeneca Plc
16 May 2014 11:00 AM
RNS
Rule 2.10 Announcement
15 May 2014 03:28 PM
BZW
Form 8.3 - AstraZeneca Plc
15 May 2014 03:02 PM
BZW
Form 8.3 - AstraZeneca Plc
15 May 2014 01:52 PM
RNS
CONTINUING PROGRESS IN LATE STAGE PIPELINE
15 May 2014 12:56 PM
BZW
Form 8.3 - AstraZeneca PLC
15 May 2014 12:06 PM
BZW
Form 8.3 - Astrazeneca Plc - Amendment
15 May 2014 11:00 AM
RNS
Rule 2.10 Announcement
15 May 2014 07:00 AM
RNS
AstraZeneca oncology pipeline update ahead of ASCO
14 May 2014 03:07 PM
BZW
Form 8.3 - AstraZeneca Plc
14 May 2014 03:00 PM
BZW
Form 8.3 - AstraZeneca Plc
14 May 2014 12:58 PM
BZW
Form 8.3 - AstraZeneca PLC
14 May 2014 11:01 AM
BZW
Form 8.3 - Astrazeneca Plc - Amendment
14 May 2014 11:00 AM
RNS
Rule 2.10 Announcement
14 May 2014 07:00 AM
RNS
MedImmune announces immuno-oncology collaboration
13 May 2014 05:18 PM
BZW
Form 8.3 - Astrazeneca Plc - Amendment
13 May 2014 03:06 PM
BZW
Form 8.3 - AstraZeneca Plc
13 May 2014 02:43 PM
BZW
Form 8.3 - Astrazenica Plc
13 May 2014 12:59 PM
BZW
Form 8.3 - AstraZeneca PLC
13 May 2014 11:17 AM
BZW
Form 8.3 - Astrazeneca Plc - AMENDMENT
13 May 2014 11:15 AM
RNS
STATEMENT REGARDING PFIZER ANNOUNCEMENT
13 May 2014 11:00 AM
RNS
Rule 2.10 Announcement
13 May 2014 10:57 AM
BZW
Form 8.3 - Astrazeneca Plc
13 May 2014 07:00 AM
RNS
AZ PHASE III SAXA/DAPA RESULTS
12 May 2014 06:16 PM
RNS
Form 8 (OPD) Pfizer Inc.
12 May 2014 06:15 PM
RNS
Form 8 (OPD) AstraZeneca PLC
12 May 2014 04:01 PM
RNS
AZ ANNOUNCES RESULTS OF PHASE IIB STUDIES
12 May 2014 04:00 PM
RNS
AZ TO PRESENT DATA AT ATS 2014

AstraZeneca plc is a British-Swedish multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, England.

It has a portfolio of products for major diseases in areas including oncology, cardiovascular, gastrointestinal, infection, neuroscience, respiratory, and inflammation. It was involved in developing the Oxford–AstraZeneca COVID-19 vaccine.

Astra Zeneca share price launched at 605p in 1993.

UK 100

Latest directors dealings